Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spiriva with or without theophylline in COPD
ChiCTR-TRC-10000943Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tiotropium and theophylline in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Frequency of acute exacerbation of chronic obstructive pulmonary disease. Started Jul 2010; status: completed.
02
Drugs
tiotropiumtheophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-10000943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000943.